# EDGAR Filing Document

**Accession Number:** 0001656081
**File Stem:** 0001656081-25-000043
**Filing Date:** 2025-9
**Character Count:** 50125
**Document Hash:** c03b10c296c3fea883d85b324c927b76
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001656081-25-000043.hdr.sgml**: 20250904

**ACCESSION NUMBER**: 0001656081-25-000043

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20250904

**DATE AS OF CHANGE**: 20250904

**EFFECTIVENESS DATE**: 20250904

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Endava plc
- **CENTRAL INDEX KEY:** 0001656081
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-290043
- **FILM NUMBER:** 251294081

**BUSINESS ADDRESS:**
- **STREET 1:** 125 OLD BROAD STREET
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** EC2N 1AR
- **BUSINESS PHONE:** 44 20 7367 1000

**MAIL ADDRESS:**
- **STREET 1:** 125 OLD BROAD STREET
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** EC2N 1AR

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Endava Ltd
- **DATE OF NAME CHANGE:** 20151019

---

| |
|:---|
| As filed with the U.S. Securities and Exchange Commission on September 4, 2025 |
| Registration No. 333- |

---

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT**

**UNDER**

**THE SECURITIES ACT OF 1933**

**ENDAVA PLC**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **England and Wales** | **Not applicable** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |

---

**125 Old Broad Street,<br>London EC2N 1AR<br>(Address of Principal Executive Offices) (Zip Code)**

**Endava plc 2018 Equity Incentive Plan <br>(Full title of the plan)**

**Endava Inc.<br>757 3rd Avenue, Suite 1901<br>New York, NY 10017<br>(212) 920-7240<br>(Name and address of agent for service) (Telephone number, including area code, of agent for service)**

***Copies to:***

**Jaime L. Chase**

**Trey Reilly**

**Cooley LLP**

**1299 Pennsylvania Avenue, NW**

**Suite 700**

**Washington, DC 20004**

**(202) 842-7800**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**EXPLANATORY NOTE**

Pursuant to General Instruction E of Form S-8, Endava plc (the "***Registrant***") is filing this Registration Statement with the Securities and Exchange Commission (the "***Commission***") to register an additional 1,189,811 Ordinary Shares issuable under the Endava plc 2018 Equity Incentive Plan (the "***2018 Plan***"), pursuant to the provisions of the 2018 Plan providing for an automatic increase in the number of shares reserved and available for issuance under the 2018 Plan on January 1, 2025.

**PART I<br>INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS**

The information specified in Part I of Form S-8 is omitted from this Registration Statement in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the "***Securities Act***"), and the introductory note to Part I of Form S-8. The document(s) containing the information specified in Part I of Form S-8 will be delivered to the participants in the plans covered by this Registration Statement as specified by Rule 428(b)(1) under the Securities Act.

**PART II<br>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.**

The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed by the Registrant with the Commission:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the contents of the Registrant's Registration Statements on Form S-8, previously filed with the Commission on <u>[December 7, 2018](https://www.sec.gov/Archives/edgar/data/1656081/000162828018014927/endava-formsx8xnov2018.htm)</u> (File No. 333-228717), <u>[September 18, 2020](https://www.sec.gov/Archives/edgar/data/1656081/000165608120000018/endavas-8september2020.htm)</u> (File No. 333-248904), <u>[September 30, 2021](https://www.sec.gov/Archives/edgar/data/1656081/000165608121000056/s-8september2021.htm)</u> (File No. 333-259900), <u>[October 31, 2022](https://www.sec.gov/Archives/edgar/data/1656081/000165608122000044/endava-2022formsx8.htm)</u> (File No. 333-268067), <u>[September 19, 2023](https://www.sec.gov/Archives/edgar/data/1656081/000165608123000043/endava-2023formsx8.htm)</u> (File No. 333-274571) and <u>[September 19, 2024](https://www.sec.gov/Archives/edgar/data/1656081/000165608124000039/endava-2024formsx8.htm)</u> (File No. 333-282207);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the Registrant's Annual Report on Form 20-F for the fiscal year ended June 30, 2025 (File No. 001-38607), filed with the Commission on <u>[September 4, 2025](https://www.sec.gov/ix?doc=/Archives/edgar/data/1656081/000165608125000039/dava-20250630.htm)</u>;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the descriptions of the Registrant's American Depositary Shares and Ordinary Shares contained in the Registrant's Registration Statement on Form 8-A filed with the Commission on <u>[July 24, 2018](https://www.sec.gov/Archives/edgar/data/1656081/000162828018009547/dava8-a12b.htm)</u> (File No. 001-38607) under the Securities Exchange Act of 1934, as amended (the "***Exchange Act***"), including any amendment or report filed for the purpose of updating such description, including (i) <u>[Exhibit 2.3(a)](https://www.sec.gov/Archives/edgar/data/1656081/000165608120000016/exhibit23afy20.htm)</u> to the Registrant's Annual Report on Form 20-F for the year ended June 30, 2020 (File. No. 00138607), filed with the Commission on September 15, 2020 and (ii) <u>[Exhibit 2.3(b)](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001656081/000165608123000041/dava-20230630.htm)</u>to the Registrant's Annual Report on Form 20-F for the year ended June 30, 2019 (File. No. 00138607), filed with the Commission on September 25, 2019.

All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents.

Any statement contained in this Registration Statement, in an amendment hereto or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed amendment to this Registration Statement or in any document that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

------

Under no circumstances shall any information subsequently furnished on Form 6-K be deemed incorporated herein by reference unless such Form 6-K expressly provides to the contrary.

**ITEM 8. EXHIBITS.**

---

| | |
|:---|:---|
| **Exhibit<br>Number** | **Description** |
| 4.1 | <u>[Articles of Association of Endava plc, as amended (incorporated by reference to Exhibit 3.1 to the Registrant's Registration Statement on Form F-1 (File No. 333-226010), filed with the Commission on June 29, 2018 (the "F-1 Registration Statement")).](https://www.sec.gov/Archives/edgar/data/1656081/000162828018008945/exhibit31f-1.htm)</u> |
| 4.2 | <u>[Form of Deposit Agreement (incorporated by reference to Exhibit (a) of the Registrant's Pre-Effective Amendment No. 1 to Form F-6 registration statement (File No. 333-226021), filed with the Commission on July 18, 2018 (the "F-6 Registration Statement")).](https://www.sec.gov/Archives/edgar/data/1472033/000119380518000985/e618175_ex99-a.htm)</u> |
| 4.3 | <u>[Form of American Depositary Receipt (incorporated by reference to Exhibit (a) of the F-6 Registration Statement).](https://www.sec.gov/Archives/edgar/data/1472033/000119380518000985/e618175_ex99-a.htm)</u> |
| 5.1\* | <u>[Opinion of Cooley (UK) LLP.](endava-cooleyukllpopinionx.htm)</u> |
| 23.1\* | <u>[Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.](ex231pwcs-8consent.htm)</u> |
| 23.2\* | Consent of Cooley (UK) LLP. Reference is made to Exhibit 5.1. |
| 24.1\* | Power of Attorney. Reference is made to the signature page hereto. |
| 99.1 | <u>[Endava plc 2018 Equity Incentive Plan (incorporated by reference to Exhibit 10.5 to the F-1 Registration Statement).](https://www.sec.gov/Archives/edgar/data/1656081/000162828018008945/exhibit105f-1.htm)</u> |
| 107\* | <u>[Fee Filing Table.](exfilingfees.htm)</u> |

---

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> 

\* Filed herewith. 

------

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of London, United Kingdom, on the 4th day of September, 2025.

**ENDAVA PL**C

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ John Cotterell</u>*<u>&nbsp;&nbsp;&nbsp;&nbsp;</u>*

John Cotterell

Chief Executive Officer

------

**POWER OF ATTORNEY**

KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints John Cotterell and Mark Thurston, and each of them, as his true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| &nbsp;&nbsp;/s/ John Cotterell | Chief Executive Officer and Director<br>*(Principal Executive Officer)* | September 4, 2025 |
| &nbsp;&nbsp;John Cotterell | Chief Executive Officer and Director<br>*(Principal Executive Officer)* | September 4, 2025 |
| &nbsp;&nbsp;/s/ Mark Thurston | Chief Financial Officer and Director<br>*(Principal Financial and Accounting Officer)* | September 4, 2025 |
| &nbsp;&nbsp;Mark Thurston | Chief Financial Officer and Director<br>*(Principal Financial and Accounting Officer)* | September 4, 2025 |
| &nbsp;&nbsp;/s/ Patrick Butcher | Director | September 4, 2025 |
| &nbsp;&nbsp;Patrick Butcher | Director | September 4, 2025 |
| &nbsp;&nbsp;/s/ Sulina Connal | Director | September 4, 2025 |
| &nbsp;&nbsp;Sulina Connal | Director | September 4, 2025 |
| &nbsp;&nbsp;/s/ Ben Druskin | Director | September 4, 2025 |
| &nbsp;&nbsp;Ben Druskin | Director | September 4, 2025 |
| &nbsp;&nbsp;/s/ Kathryn Hollister | Director | September 4, 2025 |
| &nbsp;&nbsp;Kathryn Hollister | Director | September 4, 2025 |
| &nbsp;&nbsp;/s/ David Pattillo | Director | September 4, 2025 |
| &nbsp;&nbsp;David Pattillo | Director | September 4, 2025 |
| <br>/s/ Trevor Smith | Director | September 4, 2025 |
| &nbsp;&nbsp;Trevor Smith | Director | September 4, 2025 |

---

------

**SIGNATURE OF AUTHORIZED U.S. REPRESENTATIVE**

Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Endava plc, has signed this Registration Statement on the 4th day of September, 2025.

---

| | |
|:---|:---|
| **ENDAVA INC.** | **ENDAVA INC.** |
| By: | /s/ Rohit Bhoothalingam |
|  | Name: Rohit Bhoothalingam |
|  | Title: General Counsel and Company Secretary |

---

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Calculation of Filing Fee Tables**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **S-8**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Endava plc**  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Security Type**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Security Class Title**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Fee Calculation Rule**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Amount Registered**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Proposed Maximum Offering Price Per Unit**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Maximum Aggregate Offering Price**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Fee Rate**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Amount of Registration Fee**  |
| 1 | Equity | Class A ordinary shares | Other | 1189811 | $14.26 | $16966704.86 | 0.0001531 | $2597.60 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: |  | $16966704.86  |  | $2597.60  |
| Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  |  |  |  | $0.00  |
| Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  |  |  |  | $2597.60  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Offering Note** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>1</sup> (1) These Class A ordinary shares of Endava plc (the "Registrant"), nominal value GBP 0.02 per share ("Ordinary Shares"), may be represented by the Registrant's American Depositary Shares ("ADSs"), each of which represents one Ordinary Share. (2) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional Ordinary Shares of the Registrant that become issuable under the Registrant's 2018 Equity Incentive Plan (the "2018 Plan") by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant's outstanding Ordinary Shares. (3) Represents Ordinary Shares that were automatically added to the Ordinary Shares authorized for issuance under the 2018 Plan on January 1, 2025, pursuant to an "evergreen" provision contained in the 2018 Plan. Pursuant to such "evergreen" provision contained in the 2018 Plan, on January 1st of each year from 2019 until (and including) 2028, the number of Ordinary Shares authorized for issuance under the 2018 Plan is automatically increased by a number equal to the amount equal to the lesser of (1) 2% of the total number of Ordinary Shares outstanding on December 31st of the preceding calendar year, or (2) a number of shares determined by the Registrant's board of directors. (4) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) of the Securities Act and based upon the price of $14.26 per ADS, which was the average of the high and low prices of the Registrant's ADSs as reported on the New York Stock Exchange on September 2, 2025.

---

| | |
|:---|:---|
| | |
| **Rule 457(p)** | **Rule 457(p)** |
| Fee Offset Claims | N/A |
| Fee Offset Sources | N/A |

---

## Exhibit 5.1

![image_0a.jpg](image_0a.jpg)

Claire Keast-Butler+44 (0) 20 7556 4211ckeastbutler@cooley.com<br>

Endava plc

125 Old Broad Street

London EC2N 1AR

United Kingdom

4 September 2025

Ladies and Gentlemen:

**Re:&nbsp;&nbsp;&nbsp;&nbsp;Endava plc – Registration Statement on Form S-8 – Exhibit 5.1**

**1. INTRODUCTION**

1.1We have acted as English legal advisers to Endava plc, a public limited company incorporated in England and Wales (the "**Company**"), in relation to the preparation and filing of the registration statement on Form S-8 to which this opinion letter is attached as an exhibit (such registration statement, as amended, including the documents incorporated by reference therein, the "**Registration Statement**") filed with the United States Securities and Exchange Commission (the "**SEC**") pursuant to the United States Securities Act of 1933, as amended (the "**Securities Act**") and the rules and regulations promulgated thereunder.

1.2As set out in the Registration Statement, it is proposed that up to 1,189,811 class A ordinary shares of nominal value £0.02 each in the capital of the Company (the "**Shares**") that became available for issuance under the Endava plc 2018 Equity Incentive Plan with Non-Employee Sub-Plan adopted by the Company's board of directors (the "**Board**" or the "**Directors**") on 16 April 2018 and approved by the Company's shareholders on 3 May 2018 (the "**2018 Equity Incentive Plan**") pursuant to the evergreen increase provision of the 2018 Equity Incentive Plan on 1 January 2025 in relation to future grants under the 2018 Equity Incentive Plan be registered under the Securities Act.

1.3We are rendering this letter at the request of the Company in connection with the Registration Statement. We have taken instructions solely from the Company.

1.4Except as otherwise defined in this letter, capitalised terms used have the respective meanings given to them in the Registration Statement and headings are for ease of reference only and shall not affect interpretation.

1.5All references to legislation in this letter are to the legislation of England unless the contrary is indicated, and any reference to any provision of any legislation shall include any amendment, modification, re-enactment or extension thereof, as in force on the date of this letter.

**2. DOCUMENTS** 

For the purpose of issuing this letter, we have reviewed the following documents only:

2.1a draft PDF copy of the Registration Statement as at 3 September 2025 to be filed with the SEC on 4 September 2025;

2.2a PDF copy of the 2018 Equity Incentive Plan;

2.3a PDF copy of the executed minutes of the meeting of the Board held on 16 April 2018, at which it was resolved, *inter alia*, to approve the 2018 Equity Incentive Plan (the "**Board Minutes**");

&nbsp;&nbsp;&nbsp;&nbsp;

Cooley (UK) LLP 22 Bishopsgate London EC2N 4BQ, UK<br>t: +44 (0) 20 7583 4055 f: +44 (0) 20 7785 9355 cooley.com

Cooley (UK) LLP is a limited liability partnership and is registered in England and Wales with registered number OC395270. Our registered office is at the address above. Cooley (UK) LLP is authorised and regulated by the Solicitors Regulation Authority (SRA number 617791). A list of the members of Cooley (UK) LLP and their professional qualifications is open to inspection at its registered office. The word 'partner,' used in relation to Cooley (UK) LLP, refers to a member of Cooley (UK) LLP or an employee or consultant of Cooley (UK) LLP (or any affiliated firm) of equivalent standing.

&nbsp;&nbsp;&nbsp;&nbsp;

324016715 v1<br>

------

2.4a PDF copy of the executed written resolutions of the Board passed on 4 September 2025 resolving, *inter alia*, to approve the filing of the Registration Statement (the "**Written Board Resolutions**");

2.5a PDF copy of the executed minutes of the general meeting of the Company held on 3 May 2018 at which it was resolved, *inter alia*, to approve the 2018 Equity Incentive Plan (the "**2018 Shareholder Resolutions**");

2.6a PDF copy of the executed minutes of the annual general meeting of the Company held on 12 December 2022 (the "**2022 AGM**") at which it was resolved, *inter alia*, to (i) authorise the Directors for the purposes of section 551 of the Companies Act 2006, as amended (the "**Companies Act**") to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £3,000,000 for a period expiring five years after the date on which the resolution was passed and (ii) empower the Directors to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred on them in (i) as if section 561(1) of the Companies Act did not apply to that allotment (the "**2022 Shareholder Resolutions**");

2.7a PDF copy of the certificate of incorporation of the Company dated 27 February 2006 and a PDF copy of the certificate of incorporation on re-registration of the Company as a public limited company and change of name dated 6 July 2018; and

2.8a PDF copy of the current articles of association of the Company adopted on 3 May 2018 (the "**Articles**").&nbsp;&nbsp;&nbsp;&nbsp;

**3. SEARCHES**

In addition to examining the documents referred to in paragraph 2 (*Documents*), we have carried out the following searches only:

3.1an online search at Companies House in England and Wales ("**Companies House**") with respect to the Company, carried out at 08:42 a.m. (London time) on 4 September 2025 (the "**Companies House Search**"); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2 3.3an online enquiry of the Central Registry of Winding-up Petitions at the Insolvency and Companies List in England and Wales (the "**Central Registry**") with respect to the Company, carried out at 10:07 a.m. (London time) on 4 September 2025 (the "**Central Registry Enquiry**" and, together with the Companies House Search, the "**Searches**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4 **4.OPINION**

Subject to the assumptions set out in paragraph 5 (*Assumptions*), the scope of the opinion set out in paragraph 6 (*Scope of Opinion*) and the reservations set out in paragraph 7 (*Reservations*), and subject further to the following:

4.1the Registration Statement, as finally amended, having become effective under the Securities Act;

4.2the Directors, or a duly constituted committee of the Directors to whom authority has been validly delegated (a "**Committee**"), having validly granted the awards in respect of the Shares under the 2018 Equity Incentive Plan;

4.3the Directors, or a Committee, having validly resolved to allot and issue the Shares, or grant rights to subscribe for the Shares, at duly convened and quorate meetings of the Board or such Committee as applicable, or by way of duly passed written resolutions of the Board or

324016715 v1<br>

------

such Committee as applicable in compliance with all applicable laws and regulations and with such resolutions being in full force and effect and not having been rescinded or amended;

4.4the receipt in full of payment for the Shares in an amount of "cash consideration" (as defined in section 583(3) of the Companies Act) equal to the subscription price for such Shares, assuming in each case that the individual grants or awards under the 2018 Equity Incentive Plan are duly authorised by all necessary corporate action and duly granted or awarded and exercised in accordance with the requirements of applicable law, the Articles and the 2018 Equity Incentive Plan (and the agreements and awards duly adopted thereunder and in accordance therewith); and

4.5valid entries having been made in relation to the allotment and issue of the Shares in the books and registers of the Company,

4.6it is our opinion that, as at today's date, the Shares, if and when allotted and issued, registered in the name of the recipient in the register of members of the Company and delivered in accordance with the terms and conditions referred to in the 2018 Equity Incentive Plan, and as described in the Registration Statement, will be duly and validly authorised and issued, fully paid or credited as fully paid (subject to the receipt of valid consideration by the Company for the issue thereof) and will not be subject to any call for payment of further capital.

**5. ASSUMPTIONS** 

In giving the opinion in this letter, we have assumed (without making enquiry or investigation) that:

5.1all signatures, stamps and seals on all documents are genuine. All original documents are complete, authentic and up-to-date, and all documents submitted to us as a copy (whether by email or otherwise) are complete and accurate and conform to the original documents of which they are copies and that no amendments (whether oral, in writing or by conduct of the parties) have been made to any of the documents since they were examined by us;

5.2where a document has been examined by us in draft or specimen form, it will be or has been duly executed in the form of that draft or specimen;

5.3the Articles referred to in paragraph 2.8 (*Documents*) of this letter remain in full force and effect, and no alteration has been made or will be made to the Articles, in each case prior to the relevant date of the granting of rights to subscribe for the Shares and/or the allotment and issue of the Shares (each such date, an "**Allotment Date**");

5.4at the time of each allotment and issue of any Shares the Company shall have received in full "cash consideration" (as such term is defined in section 583(3) of the Companies Act) equal to the subscription price payable for such Shares and shall have entered the holder or holders thereof in the register of members of the Company showing that all such Shares shall have been fully paid up as to their nominal value and any premium thereon as at each Allotment Date;

5.5the 2018 Equity Incentive Plan has been validly adopted and remains in full force and effect, and no alteration has been made or will be made to the 2018 Equity Incentive Plan prior to any Allotment Date;

5.6the 2018 Equity Incentive Plan (other than the Non-Employee Sub-Plan) qualifies as an "employees' share scheme" as defined in section 1166 of the Companies Act;

5.7in relation to any allotment and issue of any Shares by the Company pursuant to the 2018 Equity Incentive Plan, the recipient shall have become entitled to such Shares under the terms of the 2018 Equity Incentive Plan and such Shares, or rights over Shares, where applicable, will be fully vested in accordance with the terms of the 2018 Equity Incentive Plan

324016715 v1<br>

------

and such recipient will have complied with all other requirements of the 2018 Equity Incentive Plan in connection with the allotment and issue of such Shares;

5.8all awards will be made under the terms of the 2018 Equity Incentive Plan, that the terms of all awards will not materially deviate from the terms set out in the 2018 Equity Incentive Plan and that any Shares will be allotted and issued in accordance with the terms set out in the 2018 Equity Incentive Plan and in accordance with the Articles and applicable laws;

5.9immediately prior to each Allotment Date, the Directors shall have sufficient authority and powers conferred upon them to allot and issue such Shares and grant such rights to acquire the Shares (as applicable) under section 551 of the Companies Act (unless such allotment and issue or grant is exempt under section 549(2) of the Companies Act) and under section 570 or section 571 of the Companies Act as if section 561 of the Companies Act did not apply to such allotment and issue or grant (unless such allotment and issue or grant is exempt from section 561 of the Companies Act pursuant to section 566 of the Companies Act) pursuant to the 2022 Shareholder Resolutions and the Directors shall not allot or issue (or purport to allot or issue) Shares and shall not grant rights (or purport to grant rights) to acquire Shares in excess of such powers or in breach of any other limitation on their power to allot and issue Shares or grant rights to acquire Shares;

5.10no Shares shall be allotted or issued, or are or shall be committed to be allotted or issued, at a discount to their nominal value (whether in dollars or equivalent in any other currency);

5.11all documents, forms and notices which should have been delivered to Companies House in respect of the Company have been so delivered;

5.12the information revealed by the Searches is true, accurate, complete and up-to-date in all respects, and there is no information which should have been disclosed by the Searches that has not been disclosed for any reason and there has been no alteration in the status or condition of the Company since the date and time that the Searches were made and that the results of the Searches will remain complete and accurate as at each Allotment Date;

5.13no notice has been received by the Company which could lead to the Company being struck off the register of companies under section 1000 of the Companies Act and no such notice shall have been received as at each Allotment Date;

5.14in relation to the allotment and issue of the Shares, the Directors have acted and will act in the manner required by section 172 of the Companies Act and the Shares will be allotted and issued in good faith and on bona fide commercial terms and on arms' length terms and for the purpose of carrying on the business of the Company and that there are reasonable grounds for believing that the allotment and issue of the Shares will promote the success of the Company for the benefit of its members as a whole;

5.15there has not been and will not be any bad faith, breach of trust, fraud, coercion, duress or undue influence on the part of any of the Directors in relation to any allotment and issue of Shares;

5.16the Board Minutes referred to in paragraph 2.3 (*Documents*), provided to us in connection with the giving of this opinion, are a true record of the proceedings described therein, and that the meeting recorded in such minutes was and each meeting of the Board or a Committee referred to in paragraph 4.3 of this letter were and/or will be duly conducted as described therein, duly constituted and convened and all constitutional, statutory and other formalities were and/or will be duly observed (including, if applicable, those relating to the declaration of Directors' interests or the power of interested Directors to vote), a quorum was and/or will be present throughout, the requisite majority of Directors voted and/or will vote in favour of approving the resolutions and the resolutions passed at that meeting of the Board or such Committee, as applicable, were and/or will be duly adopted, have not been and will not be revoked or varied and remain in full force and effect and will remain so as at each relevant Allotment Date;

324016715 v1<br>

------

5.17the resolutions set out in the Written Board Resolutions referred to in paragraph 2.4 (*Documents*) were, and the written resolutions of the Board or a Committee referred to in paragraph 4.3 of this letter were and/or will be, validly passed as written resolutions in accordance with the Articles, that all eligible Directors (being all the Directors who would have been entitled to vote on the matter had it been proposed as a resolution at a Board or a Committee meeting, as applicable, but excluding any Director whose vote is not to be counted in respect of a particular matter) have and/or will have signed one or more copies of the Written Board Resolutions or the written resolutions of the Board or a Committee referred to in paragraph 4.3 of this letter, as applicable, that all relevant provisions of the Companies Act and the Articles were and/or will be complied with and the Articles were and/or will be duly observed (including, if applicable, those relating to the declaration of the Directors' interests or the power of interested Directors to vote) and such resolutions were and/or will be duly adopted, and have not been and/or will not be revoked or varied and remain and/or will remain in full force and effect;

5.18each of the 2018 Shareholder Resolutions and 2022 Shareholder Resolutions referred to in paragraphs 2.5 and 2.6 (*Documents*) were duly passed at the general meeting held on 3 May 2018 and the annual general meeting held on 12 December 2022, respectively, at which all constitutional, statutory and other filings were duly observed, a quorum of shareholders was present throughout and each of the 2018 Shareholder Resolutions and the 2022 Shareholder Resolutions have not been revoked or varied and remain in full force and effect and will remain so as at each Allotment Date and all filings required to be made with Companies House in connection therewith have been made within the relevant time limits;

5.19as at each Allotment Date, the authorities granted pursuant to the 2022 Shareholder Resolutions under section 551 and section 570 of the Companies Act will remain unutilised to the extent necessary to permit such allotment and issue, or in respect of any Allotment Date after such authorities have expired or been fully utilised or when resolutions have been passed in substitution for such authorities, the Company in general meeting having duly and validly resolved (i) as an ordinary resolution to authorise the Directors pursuant to section 551 of the Companies Act to allot the Shares, or grant rights to subscribe for the Shares, pursuant to the 2018 Equity Incentive Plan and (ii) as a special resolution to empower the Directors pursuant to section 570 or 571 of the Companies Act to allot such Shares and grant such rights (as applicable), free of the restrictions in section 561 of the Companies Act, in each case to the extent such authorities are required;

5.20the resolutions of the shareholders of the Company referred to in paragraph 5.19 will be duly passed as resolutions of the Company, all constitutional, statutory and other formalities will be observed and such resolutions will not have expired and will not be revoked or varied prior to each Allotment Date and will remain in full force and effect as at each Allotment Date;

5.21the Company has complied and will comply with all applicable anti-terrorism, anti-money laundering, sanctions and human rights laws and regulations and that each grant of rights to acquire Shares under the 2018 Equity Incentive Plan and that each allotment and issue of Shares pursuant to the 2018 Equity Incentive Plan will be consistent with all such laws and regulations;

5.22no Shares or rights to subscribe for Shares shall be offered to the public in the United Kingdom in breach of the Financial Services and Markets Act 2000 ("**FSMA**"), EU Regulation (EU) 2017/1129 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 or, as applicable, the Public Offers and Admissions to Trading Regulations 2024 and the Financial Conduct Authority's Prospectus Rules: Admission to Trading on a Regulated Market sourcebook, or of any other United Kingdom laws or regulations concerning offers of securities to the public, and no communication shall be made in relation to the Shares in breach of section 21 (*Restrictions on financial promotion*) of FSMA or any other United Kingdom laws or regulations relating to offers or invitations to subscribe for, or to acquire rights to subscribe for or otherwise acquire, shares or other securities;

324016715 v1<br>

------

5.23in issuing, allotting and granting rights to acquire Shares and administering the 2018 Equity Incentive Plan, the Company is not carrying on a regulated activity (within the meaning of section 19 (*The general prohibition*) of FSMA); and

5.24the Company has not taken any corporate or other action nor have any steps been taken or legal proceedings been started against the Company for the liquidation, winding-up, dissolution or reorganisation of, or for the appointment of a liquidator, receiver, trustee, administrator, administrative receiver or similar officer of, any such party (including the Company) or all or any of its or their assets (or any analogous proceedings in any jurisdiction) and no such steps or proceedings will have been taken as at each Allotment Date, and the Company is not unable to pay its debts as they fall due within the meaning of section 123 of the Insolvency Act 1986, as amended (the "**Insolvency Act**") and will not become unable to pay its debts within the meaning of that section as a result of any of the transactions contemplated herein, is not insolvent and has not been dissolved (although the Searches gave no indication that any winding-up, dissolution or administration order or appointment of a receiver, administrator, administrative receiver or similar officer has been made with respect to the Company) and such actions and steps will not have been taken as at any Allotment Date.

**6. SCOPE OF OPINION**

6.1The opinion given in this letter is limited to English law as it would be applied by English courts on the date of this letter.

6.2We express no opinion in this letter on the laws of any other jurisdiction. We have not investigated the laws of any country other than England and we assume that no foreign law affects the opinion stated in paragraph 4 (*Opinion*).

6.3We express no opinion as to any agreement, instrument or other document other than as specified in this letter. For the purposes of giving the opinion in paragraph 4 (*Opinion*), we have only examined and relied on those documents set out in paragraph 2 (*Documents*) and made those searches and enquiries set out in paragraph 3 (*Searches*), respectively. We have made no further enquiries concerning the Company or any other matter in connection with the giving of the opinion in paragraph 4 (*Opinion*).

6.4No opinion is expressed with respect to taxation in the United Kingdom or otherwise in this letter.

6.5We have not been responsible for investigating or verifying the accuracy of the facts or the reasonableness of any statement of opinion or intention, contained in or relevant to any document referred to in this letter, or that no material facts have been omitted therefrom.

6.6The opinion given in this letter is given on the basis of each of the assumptions set out in paragraph 5 (*Assumptions*) and is subject to each of the reservations set out in paragraph 7 (*Reservations*) to this letter. The opinion given in this letter is strictly limited to the matters stated in paragraph 4 (*Opinion*) and does not extend, and should not be read as extending, by implication or otherwise, to any other matters.

6.7This letter only applies to those facts and circumstances which exist as at today's date and we assume no obligation or responsibility to update or supplement this letter to reflect any facts or circumstances which may subsequently come to our attention, any changes in laws which may occur after today, or to inform the addressee of any change in circumstances happening after the date of this letter which would alter the opinion given in this letter.

6.8We have not been responsible for investigation or verification of statements of fact (including statements as to foreign law) or to the reasonableness of any statements of opinion in the Registration Statement, or that no material facts have been omitted therefrom.

324016715 v1<br>

------

6.9This letter is given by Cooley (UK) LLP and no partner or employee assumes any personal responsibility for it nor shall owe any duty of care in respect of it.

6.10This letter, the opinion given in it, and any non-contractual obligations arising out of or in connection with this letter and/or the opinion given in it, are governed by and shall be construed in accordance with English law as at the date of this letter.

**7. RESERVATIONS**

7.1The Companies House Search described at paragraph 3.1 (*Searches*) is not capable of revealing conclusively whether or not:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)a winding-up order has been made or a resolution passed for the winding-up of a company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)an administration order has been made; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)a receiver, administrative receiver, administrator or liquidator has been appointed,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)since notice of these matters may not be filed with the Registrar of Companies in England and Wales immediately and, when filed, may not be entered on the public database or recorded on the public microfiches of the relevant company immediately.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)In addition, such a company search is not capable of revealing, prior to the making of the relevant order, whether or not a winding-up petition or a petition for an administration order has been presented.

7.2The Central Registry Enquiry described at paragraph 3.2 (*Searches*) relates only to a compulsory winding-up and is not capable of revealing conclusively whether or not a winding-up petition in respect of a compulsory winding-up has been presented, since details of the petition may not have been entered on the records of the Central Registry immediately or, in the case of a petition presented to a District Registry and/or County Court in England and Wales, may not have been notified to the Central Registry and entered on such records at all, and the response to an enquiry only relates to the period since approximately 2016 for petitions presented in London and since approximately 2019 for petitions presented to a District Registry and/or County Court in England and Wales. We have not made enquiries of any District Registry or County Court in England and Wales.

7.3The opinion set out in this letter is subject to: (i) any limitations arising from applicable laws relating to insolvency, bankruptcy, administration, reorganisation, liquidation, moratoria, schemes or analogous circumstances; and (ii) an English court exercising its discretion under section 426 of the Insolvency Act (*co-operation between courts exercising jurisdiction in relation to insolvency*) to assist the courts having the corresponding jurisdiction in any part of the United Kingdom or any relevant country or territory.

7.4We express no opinion as to matters of fact.

7.5We have made no enquiries of any individual connected with the Company.

7.6We express no opinion on the compliance of the 2018 Equity Incentive Plan, or the compliance of any award to be made under the 2018 Equity Incentive Plan, with the rules or regulations of the New York Stock Exchange or the rules or regulations of any other securities exchange that are applicable to the Company.

7.7A certificate, documentation, notification, opinion or the like might be held by the English courts not to be conclusive if it can be shown to have an unreasonable or arbitrary basis or in the event of a manifest error.

324016715 v1<br>

------

7.8We express no opinion in relation to the legality, enforceability or validity of the 2018 Equity Incentive Plan or any award agreement entered into pursuant to the 2018 Equity Incentive Plan. In particular, but without prejudice to the generality of the foregoing, we have assumed that the Shares to be allotted under the 2018 Equity Incentive Plan or any such award agreement will be paid up in full (as to their nominal value and any premium) in cash (within the meaning of section 583 of the Companies Act) and we express no opinion as to whether any consideration other than "cash consideration" (as such term is defined in section 583(3) of the Companies Act) which might be paid, or purport to be paid, for the Shares would result in such Shares being validly issued, fully paid and not subject to any call for payment of further capital.

7.9If (a) the Company or a person to whom the Shares are to be allotted and issued (a "**Relevant Person**") is the target of economic or financial sanctions or other restrictive measures imposed in any jurisdiction ("**Sanctions**") or is owned or controlled (directly or indirectly) by or is acting on behalf of or at the direction of or is otherwise connected with a person who is a target of Sanctions or (b) a Relevant Person is incorporated or resident in or operating from a country or territory that is a target of Sanctions or (c) the rights or obligations of a Relevant Person is otherwise affected by Sanctions, then the rights and obligations of such Relevant Person under the 2018 Equity Incentive Plan may be void and/or unenforceable.

7.10We express no opinion in this letter on the application or potential application of the National Security and Investment Act 2021 in relation to the 2018 Equity Incentive Plan or any transaction contemplated thereby.

**8. DISCLOSURE AND RELIANCE** 

8.1This letter is addressed to you solely for your benefit in connection with the Registration Statement. We consent to the filing of this letter as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under section 7 of the Securities Act or the rules and regulations promulgated thereunder.

8.2This letter may not be relied upon by you for any other purpose, or furnished to, assigned to, quoted to, or relied upon by any other person, firm or other entity for any purpose, other than for the purpose set out in above in paragraph 8.1, without our prior written consent, which may be granted or withheld at our sole discretion.

8.3Yours faithfully

8.4/s/ Cooley (UK) LLP

**Cooley (UK) LLP**

324016715 v1<br>

## Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Endava plc of our report dated September 4, 2025 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in Endava plc's Annual Report on Form 20-F for the year ended June 30, 2025.

/s/ PricewaterhouseCoopers LLP <br>Reading, United Kingdom<br>September 4, 2025

PricewaterhouseCoopers LLP, 3 Forbury Place, 23 Forbury Road, Reading, Berkshire RG1 3JH

T: +44 (0) 1189 597 111, F: +44 (0) 1189 383 020, www.pwc.co.uk

PricewaterhouseCoopers LLP is a limited liability partnership registered in England with registered number OC303525. The registered office of PricewaterhouseCoopers LLP is <br>1 Embankment Place, London WC2N 6RH. PricewaterhouseCoopers LLP is authorised and regulated by the Financial Conduct Authority for designated investment business.